Vesicles as tools for the modulation of skin permeability

Expert Opinion on Drug Delivery

Volumn 4, Issue 6, 2007, Pages 579-593

  Dubey, Vaibhav ^a   Mishra, Dinesh ^a   Nahar, Manoj ^a   Jain, Narendra K ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Elastic liposomes; Ethosomes; Skin permeation; Transdermal delivery

Indexed keywords

ACICLOVIR; ANALGESIC AGENT; AZELAIC ACID; CANNABIDIOL; CHOLIC ACID; CYCLOSPORIN A; DEXAMETHASONE; DICLOFENAC; ERYTHROMYCIN; ESTRADIOL; ETHINYLESTRADIOL; GAMMA INTERFERON; GAP JUNCTION PROTEIN; HEPATITIS B SURFACE ANTIGEN; HUMAN SERUM ALBUMIN; HYDROCORTISONE; INSULIN; KETOTIFEN; LEVONORGESTREL; LIDOCAINE; LIPOSOME; MELATONIN; MINOXIDIL; PERGOLIDE; TESTOSTERONE; TETRACAINE; TRANSFENAC; TRIAMCINOLONE ACETONIDE; TRIHEXYPHENIDYL; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZIDOVUDINE;

AREA UNDER THE CURVE; CLINICAL TRIAL; DOSAGE SCHEDULE COMPARISON; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG PENETRATION; DRUG TISSUE LEVEL; DRUG TRANSPORT; HEPATITIS; HERPES LABIALIS; HUMAN; NONHUMAN; OSTEOARTHRITIS; PAW EDEMA; REVIEW; SKIN FUNCTION; SKIN PENETRATION; SKIN PERMEABILITY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STRATUM CORNEUM;

ADMINISTRATION, CUTANEOUS; ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; SKIN; SKIN ABSORPTION;

EID: 36649021562     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.4.6.579     Document Type: Review

References (98)

1. BOUWSTRA JA, HONEYWELL-NGUYEN PL, GOORIS GS, PONEC M: Structure of the skin barrier and its modulation by vesicular formulations. Progress Lipid Res. (2003) 42(1):1-36.
2. WILLIAMS ML, ELIAS PM: From basket weave to barrier: unifying concepts for the pathogenesis of disorders of cornification. Arch. Dermatol. (1993) 129(5):626-628.
3. WARNER RR, MYERS MC, TAYLOR DT: Electron probe analysis of human skin: determination of water concentratiohn profile. J. Invest. Dermatol. (1988) 90(2):218-224.
4. FORSLIND B: A domain mosaic model of the skin barrier. Acta Derm. Venereol. (1994) 74(1):1-6.
5. ILLEL B, SCHAFER H, WEPIERRE J, DOUCET O: Follicles play an important role in percutaneous absorption. J. Pharm. Sci. (1991) 880(5):424-427.
6. SCHEUPLAIN RJ: Mechanism of percutaneous absorption: routes of penetration and influence of solubility. J. Invest. Dermatol. (1965) 45(1):334-346.
7. SCHEUPLAIN RJ, BLANK IH, BRAWER GJ, MACFARLANE DJ: Percutaneous absorption of steroids. J. Invest. Dermatol. (1969) 52(1):63-70.
8. RUTHERFORD J, BLACK JG: The use of autoradiography to study the localization of germicides. Br. J. Dermatol. (1969) 81:75-87.
9. NICOLAU G, BANGHMAM RA, TONELLI A, MCWILLIAMS W, SCHILTZ J, YACOBI A: Deposition of viprostol (a synthetic PEG2) vasodilator in the skin following topical administration to laboratory animals. Xenobiotica (1987) 17:1113-1120.
10. BIDMON HJ, PITTS JD, SOLOMON HF, BONDI JV, STUMPF WE: Estradiol distribution in rat skin from topical application, studied by high neobution autoradiography. Histochemistry (1990) 95(1):43-54.
11. FABIN B, TOUITOU E: Localization of lipophilic molecules penetration into rat skin by quantitative radiography. Int. J. Pharm. (1991) 74(1):59-65.
12. FAN HR, LIN Q, MORRISSEY GR, KHAVARI PA: Immunization via hair follicles by topical application of naked DNA to normal skin. Nat. Biotechnol. (1999) 17(9):870-872.
13. HOFFMAN RM: The hair follicle as a gene therapy target. Nat. Biotechenol. (2000) 18(1):20-21.
14. ROBERTS MS, PUGH WJ, HADGRAFT J: Epidermal permeability: penetrant structure relationships. The effect of H-bonding groups in penetrants on their diffusion through the stratum corneum. Int. J. Pharm. (1996) 132(1-2):23-32.
15. BENSON HAE: Transdermal drug delivery: penetration enhancement techniques. Curr. Drug Deliv. (2005) 2(1):23-33.
16. ELSAYED MMA, ABDALLAH OY, NAGGAR VF, KHALAFALLAH NM: Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int. J. Pharm. (2007) 332(1-2):1-16.
17. BENSON HAE: Transfersomes for transdermal drug delivery. Exp. Opin. Drug Deliv. (2006) 3(6):727-737.
18. BANGHAM AD, HORNE RW: Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J. Mol. Biol. (1964) 12:660-668.
19. BANGHAM AD, STANDISH MM, WATKINS JC: Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. (1965) 13(1):238-252.
20. DUZGUNES N: Methods in Enzymology. Abelson JN, Simon MI (Eds), Elsevier, Amsterdam (2003):IX.
21. MEZEI M, GULASEKHARAM V: Liposomes - a selective drug delivery system for the topical route of administration: lotion dosage form. Life Sci. (1980) 26(18):1473-1477.
22. MEZEI M, GULASEKHARAM V: Liposomes - a selective drug delivery system for the topical route of administration: gel dosage form. J. Pharm. Pharmacol. (1982) 34(7):473-474.
23. MEZEI M: Liposomes as a skin drug delivery system. In: Topics in Pharmaceutical Sciences. Breimer DD, Speiser P (Eds), Elsevier, Amsterdam (1985):345-358.
24. WOHLRAB W, LASCH J: Penetration kinetics of liposomal hydrocortisone in human skin. Dermatologica (1987) 174(1):18-22.
25. WOHLRAB W, LASCH J: The effect of liposomal incorporation of topically applied hydrocortisone on its serum concentration and urinary excretion. Dermatol. Monatsschr. (1989) 175(6):348-352.
26. EL MAGHRABY GM, WILLIAMS AC, BARRY B W: Can drug-bearing liposomes can penetrate intact skin. J. Pharm. Pharmacol. (2006) 58:415-429.
27. SCHREIER H, BOUWSTRA J: Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J. Control. Rel. (1994) 30(1):1-15.
28. KNEPP VM, HINZ RS, SZOKA FC Jr, GUY RH: Controlled drug release from a novel liposomal delivery system. I. Investigation of transdermal potential. J. Control. Rel. (1988) 5(3):211-221.
29. GANESAN MG, WEINER ND, FLYNN GL, HO NFH: Influence of liposomal drug entrapment on percutaneous absorption. Int. J. Pharm. (1984) 20(1-2):139-154.
30. HO NFH, GANESAN MG, WEINER ND, FLYNN GL: Mechanism of topical delivery of liposomally entrapped drugs. J. Control. Rel. (1985) 2:61-65.
31. FOLDVARI M, GESZTES A, MEZEI M: Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies. J. Microencapsul. (1990) 7(4):479-489.
32. KIRJAVAINEN M, URTTI A, JAASKELAINEN I et al.: Interaction of liposomes with human skin in vitro - the influence of lipid composition and structure. Biochim. Biophys. Acta (1996) 1304(3): 179-189.
33. BLUME A, JANSEN M, GHYCZY M, GAREISS J: Interaction of phospholipids with lipid model mixtures for stratum corneum lipids. Int. J. Pharm. (1993) 99(2-3):219-228.
34. ABRAHAM W, DOWNING DT: Interaction between corneocytes and stratum corneum lipid liposomes in vitro. Biochim. Biophys. Acta (1990) 1021(2):119-125.
35. HOFLAND HE, BOUWSTRA JA, BODDE HE, SPIES F, JUNGINGER HE: Interactions between liposomes and human stratum corneum in vitro: freeze fracture electron microscopical visualization and small angle X-ray scattering studies. Br. J. Dermatol. (1995) 132(6):853-866.
36. PUGLIA C, TROMBETTA D, VENUTI V, SAIJA A, BONINA F: Evaluation of in vivo topical anti-inflammatory activity of indometacin from liposomal vesicles. J. Pharm. Pharmacol. (2004) 56(10):1225-1232.
37. EL MAGHRABY GM, WILLIAMS AC, BARRY BW: Skin hydration and possible shunt route penetration in controlled skin delivery of estradiol from ultradeformable and standard liposomes in vitro. J. Pharm. Pharmacol. (2001) 53:1311-1332.
38. HAN I, KIM M, KIM J: Enhanced transfollicular delivery of adriamycin with a liposome and iontophoresis. Exp. Dermatol. (2004) 13(2):86-92.
39. LEIB LM, RAMACHANDRAN C, EGBARIA K, WEINER N: Topical delivery enhancement with multilamellar liposomes into pilosebaceous units. I. In vitro evaluation using fluorescent techniques with the hamster ear model. J. Invest. Dermatol. (1992) 99(1):108-113.
40. DU PLESSIS J, EGBARIA K, RAMACHANDRAN C, WEINER N: Topical delivery of liposomally encapsulated γ-interferon. Antiviral. Res. (1992) 18(3-4):259-265.
41. BERNARD E, DUBOIS JL, WEPIERRE J: Percutaneous absorption of a new anti-androgen included in liposomes or in solution. Int. J. Pharm. (1995) 126(1-2):235-243.
42. LI L, HOFFMAN RM: Topical liposome delivery of molecules to hair follicles in mice. J. Dermatol. Sci. (1997) 14(2):101-108.
43. CEVC G, BLUME G: Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim. Biophys. Acta (1992) 1104(1):226-232.
44. PLANAS ME, GONZALEZ P, RODRIGUEZ L, SANCHEZ S, CEVC G: Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. Anesth. Analg. (1992) 75:615-621.
45. PAUL A, CEVC G, BACHHAWAT BK: Transdermal immunization with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes. Vaccine (1998) 16(2-3):188-195.
46. PAUL A, CEVC G: Non-invasive administration of protein antigens: transdermal immunization with the bovine serum albumin in transfersomes. Vaccine Res. (1995) 4:145.
47. GUO J, PING Q, SUN G, JIAO C: Lecithin vesicular carriers for transdermal delivery of cyclosporin A. Int. J. Pharm. (2000) 194(2):201-207.
48. CEVC G, GEBAUER D, STIEBER J, SCHATZLEIN A, BLUME G: Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim. Biophys. Acta (1998) 1368(2):201-215.
49. CEVC G: Transdermal drug delivery of insulin with ultradeformable carriers. Clin. Pharmacokinet. (2003) 42(5):461-474.
50. GUO J, PING Q, ZHANG L: Transdermal delivery of insulin in mice by using lecithin vesicles as a carrier. Drug Deliv. (2000) 7(2):113-116.
51. CEVC G, BLUME G: New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, transfersomes. Biochim. Biophys. Acta (2001) 1514(2):191-205.
52. CEVC G, BLUME G: Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, transfersomes. Biochim. Biophys. Acta (2003) 1614(2):156-164.
53. JAIN S, JAIN P, UMAMAHESHWARI RB, JAIN NK: Transfersomes - a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev. Ind. Pharm. (2003) 29(9):1013-1026.
54. JAIN S, SAPRE R, TIWARY AK, JAIN NK: Proultraflexible lipid vesicles for effective transdermal delivery of levonorgestrel: development, characterization, and performance evaluation. AAPS Pharm. Sci. Tech. (2005) 6(3):E513-E522.
55. TROTTA M, PEIRA E, DEBERNARDI F, GALLARATE M: Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int. J. Pharm. (2002) 241(2):319-327.
56. ELSAYED MM, ABDALLAH OY, NAGGAR VF, KHALAFALLAH NM: Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen. Pharmazie (2007) 62(2):133-137.
57. GARG M, MISHRA D, AGASHE H, JAIN NK: Ethinylestradiol loaded ultraflexible liposomes: pharmacokinetics and pharmacodynamics. J. Pharm. Pharmacol. (2006) 58(4):459-468.
58. DUBEY V, MISHRA D, ASTHANA A, JAIN NK: Transdermal delivery of a pineal hormone: melatonin via elastic liposomes. Biomaterials (2006) 27(18):3491-3496.
59. MISHRA D, GARG M, DUBEY V, JAIN S, JAIN NK: Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride. J. Pharm. Sci. (2007) 96(1):145-155.
60. EL MAGHRABY GM, WILLIAMS AC, BARRY BW: Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies. J. Pharm. Pharmacol. (1999) 51:1123-1134.
61. JAIN S, TIWARY AK, JAIN NK: Sustained and targeted delivery of an anti-HIV agent using elastic liposomal formulation: mechanism of action. Curr. Drug Deliv. (2006) 3(2):157-166.
62. MISHRA D, DUBEY V, ASTHANA A, SARAF DK, JAIN NK: Elastic liposomes mediated transcutaneous immunization against hepatitis B. Vaccine (2006) 24(22):4847-4855.
63. MISHRA D, MISHRA PK, DUBEY V, DABADGHAO S, JAIN NK: Evaluation of uptake and generation of immune response by murine dendritic cells pulsed with hepatitis B surface antigen loaded elastic liposomes. Vaccine (2007) 25(39-40):6939-6944.
64. VAN DEN BERGH BA, VROOM J, GERRITSEN H, JUNGINGER HE, BOUWSTRA JA: Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two-photon excitation microscopy. Biochim. Biophys. Acta (1999) 1461(1):155-173.
65. HONEYWELL-NGUYEN PL, BOUWSTRA JA: The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: a suggested mechanism of action. J. Control Rel. (2003) 86(1):145-156.
66. SCHATZLEIN A, CEVC G: Non-uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: a high-resolution confocal laser scanning microscopy study using highly deformable vesides (transfersomes). Br. J. Dermatol. (1998) 138(4):583-592.
67. HONEYWELL-NGUYEN PL, DE GRAAFF AM, JUNGINGER HE, BOUWSTRA JA: Interaction between elastic and rigid vesicles with human skin in vivo. Proc. Int. Symp. Control. Rel. Bioact. Mater. (2000) 27:237-238.
68. HONEYWELL-NGUYEN PL, ARENJA S, BOUWSTRA JA: Skin penetration and mechanisms of action in the delivery of the D2-agonist rotigotine from surfactant-based elastic vesicle formulations. Pharm. Res. (2003) 20(10):1619-1625.
69. HONEYWELL-NGUYEN PL, DE GRAAFF AM, WOUTER GROENINK HW, BOUWSTRA JA: The in vivo and in vitro interactions of elastic and rigid vesicles with human skin. Biochim. Biophys. Acta (2002) 1573(2):130-140.
70. VERMA DD, VERMA S, BLUME G, FAHR A: Particle size of liposomes influences dermal delivery of substances into skin. Int. J. Pharm. (2003) 258(1-2):141-151.
71. VAN DEN BERGH BA, BOUWSTRA JA, JUNGINGER HE, WERTZ PW: Elasticity of vesicles affects hairless mouse skin structure and permeability. J. Control. Rel. (1999) 62(3):367-379.
72. TROTTA M, PEIRA E, CARLOTTI ME, GALLARATE M: Deformable liposomes for dermal administration of methotrexate. Int. J. Pharm. (2004) 270(1-2):119-125.
73. EL MAGHRABY GM, WILLIAMS AC, BARRY BW: Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in vitro. J. Pharm. Pharmacol. (2001) 53(8):1069-1077.
74. GODIN B, TOUITOU E: Ethosomes: new prospects in transdermal delivery. Crit. Rev. Ther. Drug Carrier Syst. (2003) 20(1):63-102.
75. TOUITOU E, ALKABES M, DAYAN N: Ethosomes: novel lipid vesicular system for enhanced delivery Pharm. Res. (1997) S14:305-306.
76. TOUITOU E, DAYAN N, BERGELSON L, GODIN B, ELIAZ M: Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J. Control. Rel. (2000) 65(3):403-418.
77. DAYAN N, TOUITOU E: Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials (2000) 21(18):1879-1885.
78. HORWITZ E, PISANTY S, CZERNINSKI R, HELSER M, ELIAV E, TOUITOU E: A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. (1999) 87:700-705.
79. AINBINDER D, TOUITOU E: Testosterone ethosomes for enhanced transdermal delivery. Drug Deliv. (2005) 12(5):297-303.
80. LODZKI M, GODIN B, RAKOU L, MECHOULAM R, GALLILY R, TOUITOU E: Cannabidiol - transdermal delivery and anti-inflammatory effect in a murine model. J. Control. Rel. (2003) 93(3):377-387.
81. GODIN B, TOUITOU E: Erythromycin ethosomal systems: physicochemical characterization and enhanced antibacterial activity. Curr. Drug Deliv. (2005) 2(3):269-275.
82. PAOLINO D, LUCANIA G, MARDENTE D, ALHAIQUE F, FRESTA M: Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J. Control Rel. (2005) 106(1-2):99-110.
83. LOPEZ-PINTO JM, GONZALEZ-RODRIGUEZ ML, RABASCO AM: Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int. J. Pharm. (2005) 298(1):1-12.
84. ESPOSITO E, MENEGATTI E, CORTESI R: Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study. J. Cosmet. Sci. (2004) 55(3):253-264.
85. JAIN S, UMAMAHESHWARI R, BHADRA D, JAIN NK: Ethosomes: a novel vesicular carries for enhanced transdermal delivery of an anti HIV agent. Ind. J. Pharm. Sci. (2004) 66:72-81.
86. DUBEY V, MISHRA D, JAIN NK: Melatonin loaded ethanolic liposomes: physico-chemical characterization and enhanced transdermal delivery. Eur. J. Pharm. Biopharm. (2007) 67(2):398-405.
87. DUBEY V, MISHRA D, DUTTA T, NAHAR M, SARAF DK, JAIN NK: Dermal and transdermal delivery of an antipsoriatic agent via ethanolic liposomes. J. Contr. Rel. (In Press).
88. KADIR R, STEMPLER D, LIRON Z, COHEN S: Delivery of theophylline into excised human skin from alkanoic acid solutions: a push-pull mechanism. J. Pharm. Sci. (1987) 76(10):774-779.
89. GODIN B, TOUITOU E: Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J. Control. Rel. (2004) 94(2-3):365-379.
90. UCHEGBU IF, FLORENCE AT: Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Adv. Coll. Interf. Sci. (1995) 58:1-55.
91. VORA B, KHOPADE AJ, JAIN NK: Proniosome based transdermal delivery of levonorgestrel for effective contraception. J. Control. Rel. (1998) 54(2):149-165.
92. MANCONI M, SINICO C, VALENTI D, LAI F, FADDA AM: Niosomes as carriers for tretinoin III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int. J. Pharm. (2006) 311(1-2):11-19.
93. ALSARRA IA, BOSELA AA, AHMED SM, MAHROUS GM: Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur. J. Pharm. Biopharm. (2005) 59(3):485-490.
94. FANG JY, HONG CT, CHIU WT, WANG YY: Effect of liposomes and niosomes on skin permeation of enoxacin. Int. J. Pharm. (2001) 219(1-2):61-72.
95. GOPINATH D, RAVI D, RAO BR, APTE SS, RENUKA D, RAMBHAU D: Ascorbyl palmitate vesicles (aspasomes): formation, characterization and applications. Int. J. Pharm. (2004) 271(1-2):95-113.
96. ESSA EA, BONNER MC, BARRY BW: Electroporation and ultradeformable liposomes; human skin barrier repair by phospholipid. J. Control. Rel. (2003) 92(1-2):163-172.
97. ESSA EA, BONNER MC, BARRY BW: Iontophoretic estradiol skin delivery and tritium exchange in ultradeformable liposomes. Int. J. Pharm. (2002) 240(1-2):55-66.
98. ESSA EA, BONNER MC, BARRY BW: Electrically assisted skin delivery of liposomal estradiol; phospholipid as damage retardant. J. Control. Rel. (2004) 95(3):535-546.